MapLight Therapeutics, Inc. (MPLT)
Last updated: 2026-11-19 08:31:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
MapLight Therapeutics, Inc. (MPLT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.64, with a market capitalization of $369.29M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.06 to $40.43. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$369.29M | |
$6.50 | |
$7.17 | |
$6.50 | |
$6.57 | |
320.64K | |
460.66K | |
-- | |
$40.43 | |
$6.06 | |
-- | |
2026-09-30 |
MapLight Therapeutics, Inc. (MPLT) Latest Closing Stock Price
MapLight Therapeutics, Inc. (MPLT) last closed at $6.64 as of 2026-11-19 00:31:00, up 1.07% ($0.07) from the previous close of $6.57.
During the latest regular trading session, MPLT traded between $6.50 and $7.17, with a volume of 320.64K shares. The closing price was near the lower end and near the lower end of its 52-week range.
MapLight Therapeutics, Inc. (MPLT) 7-Day Stock Price Change
Over the past seven days, MapLight Therapeutics, Inc. (MPLT) moved from $7.44 to $6.64, representing a decline of 10.75% ($0.80).
The stock traded between $6.41 and $7.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 379.47 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
MPLT 52-Week Price Position
Position in Range: 1.7%
MPLT is currently trading at $6.64, placing it 1.7% of the way from its 52-week low of $6.06 to its 52-week high of $40.43. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is MapLight Therapeutics, Inc. (MPLT)?
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
MapLight Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 133 |
| Exchange | NASDAQ |
| Company Website |
MPLT News
Latest news related to MapLight Therapeutics, Inc. and MPLT stock.
- Read Full Article
- Read Full Article
MapLight Therapeutics Q3 EPS $(0.97) Beats $(1.16) Estimate
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(1.16) by 16.38 percent. This is a 97.39 percent increase over losses of $(37.18) per
Ways to Trade MPLT at MEXC
How to Buy MapLight Therapeutics, Inc. (MPLT) Stock on MEXC
Eligible investors can buy real shares of MapLight Therapeutics, Inc. (MPLT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is MapLight Therapeutics, Inc. (MPLT) stock price today?
2.Is MPLT stock going up or down today?
3.What is MPLT pre-market price?
4.What is MPLT after-hours price?
5.Is MPLT stock trading now?
6.Where does MPLT sit relative to its 52-week high and low?
7.What sector is MapLight Therapeutics, Inc. in?
8.What is MapLight Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is MPLT valued in terms of P/E ratio and EPS?
10.Does MapLight Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MPLT, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
MPLT Stock Calculator
Estimate the value between MPLT shares and USD.
MPLT Shares to USD
1.00 MPLT shares = 6.64 USD
Calculations are estimates based on the latest available price and are for reference only.


